ILution travoprost is under clinical development by Glaukos and currently in Pha...
Small Molecule to Target PSMA for Metastatic Hormone Refractory Prostate Cancer ...
MEDI-0618 is under clinical development by AstraZeneca and currently in Phase I ...
DFV-890 is under clinical development by Novartis and currently in Phase II for ...
OCT-461201 is under clinical development by Oxford Cannabinoid Technologies and ...
OCT-461201 is under clinical development by Oxford Cannabinoid Technologies and ...
Olanzapine ER is under clinical development by Teva Pharmaceutical Industries an...
MAS-825 is under clinical development by Novartis and currently in Phase II for ...
Olanzapine is under clinical development by Neurelis and currently in Phase I fo...
Omalizumab biosimilar is under clinical development by Teva Pharmaceutical Indus...
As Asda sets up a nationwide retail pharmacy in the UK and US grocer pharmacies ...
Precision immunology company Santa Ana Bio has announced a substantial funding i...
India-based Suven Pharmaceuticals has announced a definitive agreement to acquir...
AbbVie has made a licence agreement with FutureGen Biopharmaceutical for develop...
After a successful trial, the UK NHS has become the first to permanently adopt a...
If exercised, the option would allow Takeda to license the TKI olverembatinib ou...
